💊 医薬品 A-Z 🧬 標的 🛠 ツール 📚 ガイド
全医薬品 薬物分類 治療領域 副作用
ガイド 用語集 年表
比較 薬物の体内の旅 薬物ファミリー
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Rimabotulinumtoxinb

CHEMBL1201569 Phase 4 承認済み Protein
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Rimabotulinumtoxin B is a botulinum neurotoxin type B that cleaves the vesicle-associated membrane protein (VAMP/synaptobrevin) component of the SNARE complex at peripheral cholinergic nerve terminals, preventing acetylcholine release and causing localized, temporary muscle paralysis or glandular secretion reduction. It is approved for the treatment of cervical dystonia and hyperhidrosis, and is used off-label for spasticity in multiple sclerosis and post-stroke conditions.

治療領域

Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Rimabotulinumtoxin B is a botulinum neurotoxin type B that cleaves the vesicle-associated membrane protein (VAMP/synaptobrevin) component of the SNARE complex at peripheral cholinergic nerve terminals, preventing acetylcholine release and causing localized, temporary muscle paralysis or glandular secretion reduction. It is approved for the treatment of cervical dystonia and hyperhidrosis, and is used off-label for spasticity in multiple sclerosis and post-stroke conditions.

Yes, Rimabotulinumtoxinb is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201569. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.